PharmaResources (Shanghai) Co., Ltd. (SHE:301230)
China · Delayed Price · Currency is CNY 30.80
+0.02 (0.07%)
Sep 1, 2026, 4:00 PM EDT
SHE:301230 Market Cap
SHE:301230 has a market cap or net worth of 5.51 billion as of September 1, 2026. Its market cap has increased by 5.67% in one year.
Market Cap
5.51B
Enterprise Value
5.37B
Revenue
700.02M
Ranking
n/a
PE Ratio
149.86
Stock Price
30.80
ChartMarket Cap Chart
Since November 1, 2022, SHE:301230's market cap has increased from 3.94B to 5.51B, an increase of 39.84%. That is a compound annual growth rate of 9.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 5.51B | 34.05% |
| Dec 31, 2025 | 4.11B | 17.05% |
| Dec 31, 2024 | 3.51B | -8.90% |
| Dec 29, 2023 | 3.85B | -6.18% |
| Dec 30, 2022 | 4.11B | 4.27% |
| Nov 1, 2022 | 3.94B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Youcare Pharmaceutical Group | 6.34B |
| Novogene | 6.29B |
| Wuhan Keqian Biology Co.,Ltd | 5.85B |
| Hangzhou Biotest Biotech | 5.41B |
| Shouyao Holdings (Beijing) Co., LTD. | 5.20B |
| Shenzhen Weiguang Biological Products | 5.15B |
| Novoprotein Scientific | 5.11B |
| Boji Medical Technology | 5.07B |